Skip to main content
. 2023 Jan 4;15:2. doi: 10.1186/s13148-022-01420-6

Fig. 5.

Fig. 5

Further evaluation of the stack model for HCC screening. a The t-score of the stack model in normal controls, individuals with liver diseases and HCC patients. b The t-score in HCC patients with early and advanced stages. c Proportions of positive calling by the stack model and AFP (> 20 in HCC patients with early and advanced stages in the test set). d Proportions of positive calling by the stack model and PIVKA-II in HCC patients with early and advanced stages in the test set